As the race to find diagnostic technology for coronavirus continues, there is hope out of Israel where a startup is behind the first FDA-cleared fingerstick Complete Blood Count (CBC) analyzer. The blood samples from the fingerstick reveal critical information within minutes, giving doctors the ability to provide treatment on the spot at the point of care. FOX's Trey Yingst speaks with Eli Groner, the managing director of Koch Disruptive Technology and Yossi Pollak, CEO and co-founder of Sight Diagnostics, on the benefits of this technology for patients, doctors and insurers alike.